BLTE as reported
- Net Income
- −$78M
Net Income · +115% year on year · trailing twelve months to FY2025
- Free Cash Flow
- −$37M
Free Cash Flow · +26% year on year · trailing twelve months to FY2025
- EPS
- −$2.31
EPS · +96% year on year · trailing twelve months to FY2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net Income | −$78M | +115% | FY2025 |
| EPS | −$2.31 | +96% | FY2025 |
| ROE | −10% | n/a | FY2025 |
| ROA | −9.9% | n/a | FY2025 |
| Free Cash Flow | −$37M | +26% | FY2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Belite Bio, Inc (BLTE) - Net IncomeNet IncomeBelite Bio, Inc (BLTE)